Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was the bioequivalence of a Roxane Laboratories' Amlodipine
Besylate tablets, 10 mg, to Norvasc® Tablets, 10 mg (Pfizer) under fed conditions using a
single-dose, randomized, 2-treatment, 2-period, 2-sequence crossover design.